STOCK TITAN

Luduson G Financials

LDSN
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2025 Currency USD FYE December

This page shows Luduson G (LDSN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
1/9

Luduson G passes 1 of 9 financial strength tests. No profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
-$8.4M
YoY-2683.8%

Luduson G reported -$8.4M in net income in fiscal year 2025. This represents a decrease of 2683.8% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$12K
YoY-93.1%
5Y CAGR-14.8%

Luduson G held $12K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
563M
YoY+11.9%

Luduson G had 563M shares outstanding in fiscal year 2025. This represents an increase of 11.9% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

LDSN Income Statement

Metric Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue $0 N/A $0-100.0% $12.5M+733.3% $1.5M N/A $0 $0
Cost of Revenue $0 N/A $0 $0 $0 N/A $0 $0
Gross Profit $0 N/A $0-100.0% $12.5M+733.3% $1.5M N/A $0 $0
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $4K N/A $1.5M+20174.3% $7K+49.7% $5K N/A $211K+6239.0% $3K
Operating Income -$4K N/A -$1.5M-112.0% $12.5M+735.6% $1.5M N/A -$211K-6239.0% -$3K
Interest Expense N/A N/A N/A N/A $30K N/A $7K N/A
Income Tax $0 N/A $0 $0 $0 N/A $0 $0
Net Income -$4K N/A -$1.5M-112.1% $12.5M+752.7% $1.5M N/A -$217K-6439.0% -$3K
EPS (Diluted) $0.00 N/A $0.00-100.0% $0.02 $0.00 N/A $0.00 $0.00

LDSN Balance Sheet

Metric Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Total Assets $12K0.0% $12K-99.9% $22.1M-6.4% $23.6M+113.1% $11.1M+56.0% $7.1M-0.2% $7.1M $0
Current Assets $12K0.0% $12K-99.9% $12.8M-10.6% $14.3M+712.6% $1.8M+515.5% $285K-3.7% $296K $0
Cash & Equivalents $12K0.0% $12K-91.7% $146K-6.2% $156K+7.1% $145K-16.9% $175K-24.6% $232K+1826.0% $12K
Inventory $0 $0 $0-100.0% $46K $0-100.0% $46K N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A $806K0.0% $806K0.0% $806K0.0% $806K0.0% $806K N/A
Total Liabilities $104K+3.5% $101K-92.1% $1.3M0.0% $1.3M+2.1% $1.3M+0.6% $1.2M+6.1% $1.2M+1340.5% $82K
Current Liabilities $104K+3.5% $101K-65.5% $292K+0.1% $292K+10.2% $265K+2.7% $258K+70.3% $151K+85.8% $82K
Long-Term Debt N/A N/A $987K0.0% $987K0.0% $987K0.0% $987K-3.4% $1.0M N/A
Total Equity -$92K-4.0% -$89K-100.4% $20.8M-6.8% $22.3M+127.3% $9.8M+67.8% $5.8M-1.4% $5.9M+7373.7% -$82K
Retained Earnings -$22.8M0.0% -$22.8M-1092.1% -$1.9M-376.4% -$401K+96.9% -$12.9M+10.2% -$14.3M-0.6% -$14.3M-1177.2% -$1.1M

LDSN Cash Flow Statement

Metric Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Operating Cash Flow $0 N/A -$10K-193.8% $10K+134.8% -$30K N/A -$75K $0
Capital Expenditures $0 N/A $0 $0 $0 N/A $0 $0
Free Cash Flow $0 N/A -$10K-193.8% $10K+134.8% -$30K N/A -$75K $0
Investing Cash Flow $0 N/A $0 $0 $0 N/A $0 $0
Financing Cash Flow $0 N/A $0 $0 $0 N/A $295K $0
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

LDSN Financial Ratios

Metric Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Gross Margin N/A N/A N/A 100.0%0.0pp 100.0% N/A N/A N/A
Operating Margin N/A N/A N/A 99.9%+0.3pp 99.7% N/A N/A N/A
Net Margin N/A N/A N/A 99.8%+2.3pp 97.6% N/A N/A N/A
Return on Equity N/A N/A -7.3%-63.2pp 56.0%+41.0pp 14.9% N/A -3.7% N/A
Return on Assets -29.2% N/A -6.8%-59.8pp 52.9%+39.7pp 13.2% N/A -3.1% N/A
Current Ratio 0.120.0 0.12-43.6 43.68-5.2 48.90+42.3 6.63+5.5 1.11-0.9 1.96+2.0 0.00
Debt-to-Equity -1.130.0 -1.14-1.2 0.050.0 0.04-0.1 0.10-0.1 0.170.0 0.17+1.2 -1.00
FCF Margin N/A N/A N/A 0.1%+2.1pp -2.0% N/A N/A N/A

Note: Shareholder equity is negative (-$89K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.12), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

No, Luduson G (LDSN) reported a net income of -$8.4M in fiscal year 2025.

Luduson G (LDSN) had $12K in total assets as of fiscal year 2025, including both current and long-term assets.

Luduson G (LDSN) had 563M shares outstanding as of fiscal year 2025.

Luduson G (LDSN) had a current ratio of 0.12 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Luduson G (LDSN) had a debt-to-equity ratio of -1.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Luduson G (LDSN) had a return on assets of -70015.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Luduson G (LDSN) has negative shareholder equity of -$89K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Luduson G (LDSN) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Back to top